Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients
Conclusion: In comparison with SBRT, RFA did not seem to adversely affect CSS and OS of IA NSCLC patients who were not suitable for surgical treatment. In addition, RFA seemed to offer better survival to IA NSCLC patients, especially those with tumors <1 cm.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Ming Li, Xiao Xu, Yingyi Qin, Peng Zhang, Changxing Shen, Qing Xia, Lihong Fan Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Epidemiology | Lung Cancer | Non-Small Cell Lung Cancer | Statistics | Study